|
|
| A Full-Service Solution Partner Disrupting the Outsourcing Paradigm | inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them. |
|
|
|
| Should We Be Scared Of PE Firms Investing In Sites? | From The Editor | By Dan Schell, chief editor, Clinical Leader | It seems lately there's been a lot of vilification of private equity (PE) firms that are purchasing site networks. I'm sure this sentiment has increased during the past few years, but is it justified? |
|
|
|
|
| Why IQVIA Participant Payments? | Datasheet | IQVIA Technologies | Learn about how this participant-friendly technology ensures efficient and secure payments, enhancing the clinical trial experience for all involved. |
|
|
|
|
|
| AI is transforming clinical trials — are you ready to harness its potential? Join Clinical Leader Live on January 14th to explore real-world applications of AI that optimize trial design, enhance data analysis, and accelerate timelines. Don’t miss this chance to stay ahead in clinical research! Attendance is free thanks to the support of The PPD clinical research business of Thermo Fisher Scientific. |
|
|
|
| Diversifying Diabetes Trials with DAPs, Omics, And Community Engagement | Guest Column | A conversation with Luke Twelves, MA, MB BChir, MRCGP, PGDipBA, general practitioner and medical director | General practitioner and medical director Dr. Luke Twelves emphasizes the importance of more inclusive clinical trials, discussing the role of -omics and the potential impact of FDA-mandated diversity action plans (DAPs). |
|
|
|
|
| Home Trial Support | Product | MRN - Medical Research Network | Our patient-centric delivery means we can create convenience and comfort working the schedule of the trial around the schedule of the patient and their family, not the other way around. |
|
|
|
| Enrollment Mishap Emboldens Patient To Advocate For Minority Participation | Guest Column | A conversation with Tony Newberne, patient advocate for the PAN Foundation | In this series on underserved patient enrollment, PAN Foundation patient advocate Tony Newberne shares how narrowly he missed trial enrollment and how the experience inspired him to advocate for clinical research in minority communities. |
|
|
|
|
| Flatiron Prospective Evidence Generation | Case Study | Flatiron Health | Explore prospective evidence generation and pragmatic approaches that can help you address staffing challenges and the issue of complexity that is driving up the failure rate of clinical studies. |
|
|
| Connect With Clinical Leader: |
|
|
|
